Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-429074

Director bought 3,789 shares at $26.39 ($99,992)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young Wendy B. Director 2026-10-22 Purchase +3,789 $26.39 $99,992 13,289 D
Open-market purchases · 3,789 sh · avg $26.39 · $99,992
Loading xslF345X06/ownership.xml…